Pediatric rheumatology for the adult rheumatologist

Journal of Clinical Rheumatology

Volumn 14, Issue 2, 2008, Pages 109-119

  Wagner Weiner, Linda ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; CELECOXIB; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DICLOFENAC; ETANERCEPT; IBUPROFEN; IMMUNOGLOBULIN; INDOMETACIN; INFLIXIMAB; INTERLEUKIN 6 ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MYDRIATIC AGENT; NAPROXEN; PARACETAMOL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SIMVASTATIN; STEROID; SULINDAC; THALIDOMIDE; TOLMETIN; UNINDEXED DRUG;

ANAPHYLACTOID PURPURA; ANEURYSM; AVASCULAR NECROSIS; BACTERIAL ARTHRITIS; BODY HEIGHT; CHONDROLYSIS; CINCA SYNDROME; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ENTHESITIS; EPIPHYSIOLYSIS; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; FEVER; FUNCTIONAL STATUS; GLAUCOMA; GROWTH DISORDER; GROWTH INHIBITION; HEMATOLOGIC DISEASE; HEREDITARY PERIODIC FEVER; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; HYPERLIPIDEMIA; INFLAMMATORY DISEASE; JOINT HYPERMOBILITY; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LEUKOENCEPHALOPATHY; LOW DRUG DOSE; MACROPHAGE ACTIVATION SYNDROME; MONOTHERAPY; MUCKLE WELLS SYNDROME; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUSCULOSKELETAL PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; OSTEOPOROSIS; OSTEOSARCOMA; PERICARDITIS; PERTHES DISEASE; PFAPA SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHEUMATIC DISEASE; SCLERODERMA; SIDE EFFECT; SINGLE DRUG DOSE; SOCIAL PSYCHOLOGY; SPONDYLOARTHROPATHY; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TONSILLECTOMY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; UVEITIS;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; HUMANS; MUSCULOSKELETAL DISEASES; PEDIATRICS; QUALITY OF LIFE; RHEUMATIC DISEASES;

EID: 42049087058     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31816b4460     Document Type: Review

References (37)

1. Mayer ML, Mellins ED, Sandborg CI. Access to pediatric rheumatology care in the United States. Arthritis Rheum. 2003;49:759-765.
2. Lehman TJA, McCurdy DK, Bernstein BH, et al. Systemic lupus erythematosus in the first decade of life. Pediatrics. 1989;83:235-239.
3. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol. 1998;25:1991-1994.
4. Melin-Aldana H, Giannini EH, Taylor J, et al. Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J Pediatr. 1992;121:56-60.
5. Cassidy J, Kivlin J, Lindsley C, et al; and the section on Rheumatology and the Section of Ophthalmology. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006;117:1843-1845.
6. Cabral DA, Petty RE, Malleson PN, et al. Visual prognosis in children with chronic anterior uveitis and arthritis. J Rheum. 1994;21:2370-2375.
7. Wagner-Weiner L. Laboratory evaluation of pediatric rheumatic diseases. Pediatric Annals. 2002;31:362-371.
8. Harel L, Wagner-Weiner L, Poznanski A, et al. Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis (JRA). Arthritis Rheum. 1993;36:1370-1374.
9. Hashkes PJ, Laxer RM. Update on the medical treatment of juvenile idiopathic arthritis. Current Rheum Reports. 2006;8:450-458.
10. Jundt JW, Browne BA, Fiocco GP, et al. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol. 1993;20:1845-1849.
11. Ramanan AV, Whitworth P, Baildam EM. Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child. 2003;88:197-200.
12. Ramanan AA, Grom AA. Does systemic-onset idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology. 2005;44:1350-1353.
13. De Benedetti F, Martini A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J Rheumatol. 1998;25:203-207.
14. Lomater C, Gerloni V, Gattinara M, et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol. 2000;27:491-496.
15. Spiegel LR, Schneider R, Lang BA, et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum. 2000;43:2402-2409.
16. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 2004;50:689-698.
17. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infections. J Pediatr. 1985;106:561-566.
18. Mouy R, Stephan JL, Pillet P, et al. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr. 1996;129:750-754.
19. Duffy MC, Lovell DJ. Assessment of health status, function, and quality of life outcomes: methodology and instruments. In: Cassidy JT, Petty RE, Laxer RM, et al, eds. Textbook of Pediatric Rheumatology. 5th ed. Philadelphia: Elsevier Saunders; 2005:174-183.
20. Chang WL, Yang YH, Lin YT, et al. Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients. Acta Paediatrica. 2004;93:1427-1431.
21. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708-1733.
22. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
23. Newburger JA, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
24. Newburger JW, Sleeper LA, McCrindle BW, et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663-675.
25. Padeh S. Periodic fever syndromes. Pediatr Clin North Am. 2005;52:577-609.
26. Thomas KT, Feder HM, Lawton AR, et al. Periodic fever syndrome in children. J Peds. 1999;135:1-12.
27. Fink CW, Nelson JD. Septic arthritis and osteomyelitis in children. Clin Rheum Dis. 1986;12:423-435.
28. Jimenez S, Cervera R, Font J, et al. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003;25:3-12.
29. Tucker LB, Menon S, Schaller JG, et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br Society Rheum. 1995;34:866-872.
30. Carreno L, Lopez-Longo FJ, Monteagudo I, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus. 1999;8:287-292.
31. Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum. 2003;49:501-507.
32. Moorthy LN, Peterson M, Harrison MJ, et al. Quality of life in children with systemic lupus erythematosus: a review. Lupus. 2007;16:663-669.
33. Pachman LM. Juvenile dermatomyositis: pathophysiology and disease expression. Pediatr Clin North Am. 1995;42:1071-1098.
34. Huber AM, Feldman BM, Rennebohm RM, et al; Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2004;50:1595-1603.
35. Peterson LS, Nelson AM, Su DW. Classification of Morphea (Localized Scleroderma). Mayo Clin Proc. 1995;70:1068-1076.
36. Cassidy JT, Lindsley CB. Legal rights of children with musculoskeletal disabilities. Bull Rheum Dis. 1996;45:1-5.
37. White PH. Success on the road to adulthood: issues and hurdles for adolescents with disabilities. Rheum Dis North Am. 1997;23:697-707.